focus -WSS

focus

author：comprehensive 2025-09-30 11:06:57 - browse：394

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Why do we get seasonal allergies?

Wikipedia

WSS

White House launches permanent pandemic office

Illumina to lay off 10% of research and development team

Supreme Court strikes down Biden student loan forgiveness program

ADA: All diabetes patients should be screened for liver condition

Body of missing toddler recovered in Delaware River days after flood: Police

The strange history of BMI, the body mass index

Wikipedia

focus

A Worst CEO gets some much-needed help

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Tuskegee Airman Raymond Cassagnol dies at 102

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What to know about Saharan dust affecting the US and how it can affect health

Medical leaders decry Supreme Court decision on affirmative action

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Hepatitis C has a cure — but many Americans still lack access to it

Russian special forces kill a gunman who broke into a private house near Moscow

DIEP, the 'gold standard' of breast reconstruction, is under threat

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

hotspot

Brazil's Jair Bolsonaro is barred from running for office until 2030

A double vaccine crisis is endangering millions of children

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Medical experts exlpore how to eliminate bias in clinical algorithms

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Synthetic human embryos? Researchers say term is overblown

Wikipedia

hotspot

hotspot

focus